[go: up one dir, main page]

AU2001278123A1 - Process for preparing polymer-based sustained release compositions - Google Patents

Process for preparing polymer-based sustained release compositions

Info

Publication number
AU2001278123A1
AU2001278123A1 AU2001278123A AU7812301A AU2001278123A1 AU 2001278123 A1 AU2001278123 A1 AU 2001278123A1 AU 2001278123 A AU2001278123 A AU 2001278123A AU 7812301 A AU7812301 A AU 7812301A AU 2001278123 A1 AU2001278123 A1 AU 2001278123A1
Authority
AU
Australia
Prior art keywords
sustained release
release compositions
preparing polymer
based sustained
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001278123A
Inventor
Warren E. Jaworowicz
James I. Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alkermes Controlled Therapeutics Inc
Original Assignee
Alkermes Inc
Alkermes Controlled Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/638,165 external-priority patent/US6296842B1/en
Application filed by Alkermes Inc, Alkermes Controlled Therapeutics Inc filed Critical Alkermes Inc
Publication of AU2001278123A1 publication Critical patent/AU2001278123A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001278123A 2000-08-10 2001-07-30 Process for preparing polymer-based sustained release compositions Abandoned AU2001278123A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/638,165 2000-08-10
US09/638,165 US6296842B1 (en) 2000-08-10 2000-08-10 Process for the preparation of polymer-based sustained release compositions
US09/801,272 US6479065B2 (en) 2000-08-10 2001-03-07 Process for the preparation of polymer-based sustained release compositions
US09/801,272 2001-03-07
PCT/US2001/024166 WO2002013783A2 (en) 2000-08-10 2001-07-30 Process for preparing polymer-based sustained release compositions

Publications (1)

Publication Number Publication Date
AU2001278123A1 true AU2001278123A1 (en) 2002-02-25

Family

ID=27093011

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001278123A Abandoned AU2001278123A1 (en) 2000-08-10 2001-07-30 Process for preparing polymer-based sustained release compositions

Country Status (3)

Country Link
US (1) US6479065B2 (en)
AU (1) AU2001278123A1 (en)
WO (1) WO2002013783A2 (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
AU2002324447B2 (en) 2001-06-22 2006-06-29 Durect Corporation Zero-order prolonged release coaxial implants
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US7736391B2 (en) 2003-02-06 2010-06-15 Tonaba Healthscience Ii, Llc Cosmetic and reconstructive prostheses with a microencapsulated biologically compatible rupture indicator for sustained release and methods of detecting compromise of a prosthesis
ES2375802T3 (en) * 2004-04-15 2012-03-06 Alkermes Pharma Ireland Limited POLE BASED SUSTAINED RELEASE DEVICE.
US7456254B2 (en) * 2004-04-15 2008-11-25 Alkermes, Inc. Polymer-based sustained release device
RU2527893C2 (en) 2004-07-19 2014-09-10 Биокон Лимитед Insulin-oligomer conjugates, preparations and applications thereof
EP2594259A1 (en) * 2004-08-04 2013-05-22 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
EP1679065A1 (en) * 2005-01-07 2006-07-12 OctoPlus Sciences B.V. Controlled release compositions for interferon based on PEGT/PBT block copolymers
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
MX2008002370A (en) 2005-08-19 2008-04-29 Amylin Pharmaceuticals Inc Exendin for treating diabetes and reducing body weight.
US20070106271A1 (en) * 2005-11-09 2007-05-10 Searete Llc, A Limited Liability Corporation Remote control of substance delivery system
CN101453982B (en) 2006-05-30 2011-05-04 精达制药公司 Two-Piece Internal Channel Osmotic Delivery System Flow Regulator
NZ593017A (en) 2006-08-09 2011-08-26 Intarcia Therapeutics Inc Piston assembly for positioning lumen in an osmotic delivery system having groove to retain elastomeric O-ring
ATE539102T1 (en) 2006-10-31 2012-01-15 Surmodics Pharmaceuticals Inc SPHERICAL POLYMER PARTICLES
US7718616B2 (en) 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
RU2440097C2 (en) 2007-04-23 2012-01-20 Интарсия Терапьютикс, Инк. Method of treating insulin-independent diabetes and obesity, osmotic delivery system and method for making it
US8728528B2 (en) 2007-12-20 2014-05-20 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
WO2009143285A2 (en) 2008-05-21 2009-11-26 Amylin Pharmaceuticals, Inc. Exendins to lower cholestrol and triglycerides
PL2341905T5 (en) 2008-09-04 2024-01-15 Amylin Pharmaceuticals, Llc Sustained release formulations using non-aqueous carriers
US7897164B2 (en) * 2008-10-30 2011-03-01 Warsaw Orthopedic, Inc Compositions and methods for nucleus pulposus regeneration
EP2389160B1 (en) * 2009-01-23 2017-09-13 Evonik Corporation Continuous double emulsion process for making microparticles
US20100278895A1 (en) 2009-04-30 2010-11-04 Medtronic, Inc. Antioxidants and antimicrobial accessories including antioxidants
US20110027229A1 (en) 2009-07-31 2011-02-03 Medtronic, Inc. Continuous subcutaneous administration of interferon-alpha to hepatitis c infected patients
BR112012006103B8 (en) * 2009-09-17 2021-05-25 Evonik Corp implant device and kit
EP2480200A2 (en) * 2009-09-22 2012-08-01 Evonik Degussa Corporation Implant devices having varying bioactive agent loading configurations
SMT201700583T1 (en) 2009-09-28 2018-01-11 Intarcia Therapeutics Inc Rapid establishment and/or termination of substantial steady-state drug delivery
AU2011329054B2 (en) 2010-11-15 2015-05-28 Zimmer Orthobiologics, Inc. Bone void fillers
US8911427B2 (en) 2010-12-28 2014-12-16 Medtronic, Inc. Therapeutic agent reservoir delivery system
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
HRP20211768T1 (en) 2015-05-22 2022-02-18 The Board Of Trustees Of The Leland Stanford Junior University Treatment of post-bariatric hypoglycemia with glp-1 antagonists
JP6993235B2 (en) 2015-06-03 2022-01-13 インターシア セラピューティクス，インコーポレイティド Implant installation and removal system
WO2017152014A1 (en) 2016-03-04 2017-09-08 Eiger Biopharmaceuticals, Inc. Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives
EP3733694A1 (en) 2016-05-16 2020-11-04 Intarcia Therapeutics, Inc Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
WO2018057977A1 (en) 2016-09-23 2018-03-29 Delpor, Inc. Stable compositions for incretin mimetic compounds
EP4591853A1 (en) 2016-11-21 2025-07-30 Amylyx Pharmaceuticals, Inc. Buffered formulations of exendin (9-39)
JP7286542B2 (en) 2017-01-03 2023-06-05 インターシア セラピューティクス，インコーポレイティド A method comprising continuous administration of a GLP-1 receptor agonist and co-administration of drugs
EP4065086B1 (en) * 2019-11-25 2026-01-28 Regeneron Pharmaceuticals, Inc. Sustained release formulations using non-aqueous emulsions

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2648609A (en) 1949-01-21 1953-08-11 Wisconsin Alumni Res Found Method of applying coatings to edible tablets or the like
BE590276A (en) 1959-04-30
US3117027A (en) 1960-01-08 1964-01-07 Wisconsin Alumni Res Found Apparatus for coating particles in a fluidized bed
US3207824A (en) 1962-06-22 1965-09-21 Wisconsin Alumni Res Found Process for preparing agglomerates
US3196827A (en) 1962-11-19 1965-07-27 Wisconsin Alumni Res Found Apparatus for the encapsulation of discrete particles
US3253944A (en) 1964-01-13 1966-05-31 Wisconsin Alumni Res Found Particle coating process
US3241520A (en) 1964-10-19 1966-03-22 Wisconsin Alumni Res Found Particle coating apparatus
US4134742A (en) 1977-06-06 1979-01-16 Envirogenic Systems Company Gas separation membranes
US4981696A (en) * 1986-12-22 1991-01-01 E. I. Du Pont De Nemours And Company Polylactide compositions
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US4898734A (en) * 1988-02-29 1990-02-06 Massachusetts Institute Of Technology Polymer composite for controlled release or membrane formation
US4902515A (en) * 1988-04-28 1990-02-20 E. I. Dupont De Nemours And Company Polylactide compositions
US5019400A (en) 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres
US5656297A (en) 1992-03-12 1997-08-12 Alkermes Controlled Therapeutics, Incorporated Modulated release from biocompatible polymers
US5716644A (en) 1992-06-11 1998-02-10 Alkermes, Inc. Composition for sustained release of non-aggregated erythropoietin
US5711968A (en) 1994-07-25 1998-01-27 Alkermes Controlled Therapeutics, Inc. Composition and method for the controlled release of metal cation-stabilized interferon
EP1013270A3 (en) 1992-12-02 2001-03-28 Alkermes Controlled Therapeutics, Inc. Controlled release growth hormone containing microspheres
US5582838A (en) 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
US5922253A (en) 1995-05-18 1999-07-13 Alkermes Controlled Therapeutics, Inc. Production scale method of forming microparticles
WO1997007788A2 (en) 1995-08-31 1997-03-06 Alkermes Controlled Therapeutics, Inc. Composition for sustained release of an agent
TW448055B (en) 1995-09-04 2001-08-01 Takeda Chemical Industries Ltd Method of production of sustained-release preparation
US5945284A (en) 1997-05-27 1999-08-31 The Perkin-Elmer Corporation Length determination of nucleic acid repeat sequences by discontinuous primer extension
US6187329B1 (en) * 1997-12-23 2001-02-13 Board Of Regents Of The University Of Texas System Variable permeability bone implants, methods for their preparation and use

Also Published As

Publication number Publication date
US6479065B2 (en) 2002-11-12
WO2002013783A2 (en) 2002-02-21
US20020037309A1 (en) 2002-03-28
WO2002013783A3 (en) 2002-08-15
WO2002013783A8 (en) 2002-10-03

Similar Documents

Publication Publication Date Title
AU2001278123A1 (en) Process for preparing polymer-based sustained release compositions
AU2002300377A1 (en) Compositions for controlled release
HUP0302060A3 (en) Method for preparing compositions
AU2002229140A1 (en) Controlled release pharmaceutical composition
AU2002230470A1 (en) Process for preparing pouches
AU2001261434A1 (en) Aldosterone antagonist composition for release during aldosterone acrophase
AU2001258801A1 (en) Gelling composition
AU2002216087A1 (en) Novel substituted imidazotriazinones as pde ii-inhibitors
SG84623A1 (en) Controlled release compositions
AU2001276749A1 (en) Polymer composition
AU2001267708A1 (en) Novel process for preparing crystalline particles
AU2001248772A1 (en) Sustained release drug compositions
AU2001227086A1 (en) Process for preparing 2-hydroxy-4-methylthiobutanoic acid
AU2001291313A1 (en) Process for making 3-amino-2-chloro-4-methylpyridine
AU2001253298A1 (en) Method for preparing aqueous size composition
AU4626200A (en) Process for preparing uniformly consistent radiation-curable compositions
AUPR040900A0 (en) Mould release composition
AU2002215370A1 (en) Process for preparing vinyl-substituted heterocycles
AU2001255460A1 (en) Process for preparing lipid ii
AU2002222604A1 (en) Process for preparing substance GM-95
AU2001242735A1 (en) Process for producing camptothecin
AU2001280244A1 (en) Novel process for preparing 3-aminomethyl-4-z-methoxyiminopyrrolidine
AU2001267541A1 (en) Vaccine composition
AU2001255430A1 (en) Methods for producing surfactants with cellulose compositions
AU4879401A (en) Process for producing water-soluble polymer